top of page

Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB


Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...


Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...


The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
Bain Capital to Buy Olympus Science-Optics Unit for $3.1 Billion
New York City, NY, August 29, 2022 (Bloomberg) -- Bain Capital agreed to buy Olympus Corp.’s scientific instruments business for 428...
Digital Diagnostics Closes $75 million Series B Funding Round led by KKR
Coralville, IA, August 23, 2022 (PRNewswire) -- Digital Diagnostics, a leading artificial intelligence diagnostic health care...
Orna Therapeutics Raises $221 Million Series B
Cambridge, MA, August 16, 2022 (PRNewswire) -- Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered...
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C
San Francisco, CA, August 10, 2020 (BUSINESS WIRE) -- Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed...
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
Foster City, CA, August 15, 2020 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest...
Philips Names New CEO Who Has Led Respiratory Device Recall
New York City, NY, August 16, 2020 (Bloomberg) -- Royal Philips NV said Roy Jakobs, who has been leading the company’s response to a...
Sanofi and Atomwise Ink Deal Worth over $1B
San Francisco, CA, July 17, 2020 (BUSINESS WIRE) -- Atomwise, a leader in using artificial intelligence (AI) for small molecule drug...
Poseida inks deal with Roche for $110M initially and potentially $6B in aggregate value.
San Diego, CA, August, 3, 2022 (street insider) — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company...
IDRx Launches with $122 Million Series A Financing to Treat Cancer with Purpose-Built Precision Comb
IDRx aims to develop precision cancer medicines with a priori engineered, selective combinations to stop key tumor escape mechanisms and...
Sironax Announces Closing of $200 Million Series B Financing
Financing from new and existing investors will support pipeline progression and expansion for age-related degenerative diseasess BEIJING,...


Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer
LEIDEN, Netherlands, Aug. 1, 2022 (PRNewswire) — Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced...
Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointme
Nijmegen, Netherlands and Newark, N.J., July 26, 2022 (PRNewswire) — Pleco Therapeutics BV, a specialty biopharmaceutical company...
bottom of page

